التفاصيل البيبلوغرافية
العنوان: |
Table S2 from Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti–c-Met Antibody, in Patients with Advanced Solid Tumors |
المؤلفون: |
Ramesh K. Ramanathan, Louie Naumovski, Daniel Afar, Edward Reilly, Lan Wang, Huibin Yue, Shekman Wong, Monica Motwani, Peter Ansell, Chia-Chi Lin, Chia Jui Yen, Yoon-Koo Kang, Ravi Salgia, Patricia LoRusso, John H. Strickler |
بيانات النشر: |
American Association for Cancer Research (AACR), 2023. |
سنة النشر: |
2023 |
الوصف: |
Additional details for MET-amplified patients with one or more postbaseline tumor assessment (n=9). |
DOI: |
10.1158/1535-7163.22518666 |
URL الوصول: |
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::724d29e98782b3d44b4991678c167d4f https://doi.org/10.1158/1535-7163.22518666 |
Rights: |
OPEN |
رقم الانضمام: |
edsair.doi.dedup.....724d29e98782b3d44b4991678c167d4f |
قاعدة البيانات: |
OpenAIRE |